Literature DB >> 8212580

Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells.

P Somogyi1, J Frazier, M A Skinner.   

Abstract

Fowlpox virus (FPV), type species of the Avipoxvirus genus, causes a slow-spreading pox disease of chickens. Following infection of mammalian cells there is no evidence of productive replication of FPV although cytopathic effects are induced and FPV recombinants have been shown to express foreign genes from vaccinia virus early/late promoters. Here we report results of a study to investigate the expression of FPV genes, the replication of FPV genomic DNA, and any ultrastructural changes in mammalian cells infected by wild-type virus, undertaken as a first step in elucidating the nature of the block (or blocks) to productive replication of FPV in mammalian cells. Early and late gene expression as well as genomic DNA replication was observed in fibroblast-like cell lines of monkey and human origin. Furthermore, viral morphogenesis was observed in monkey cells, with the production mainly of immature particles though smaller numbers of apparently mature virus particles were observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212580     DOI: 10.1006/viro.1993.1608

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

Review 1.  Viral vector-based therapeutic cancer vaccines.

Authors:  Cecilia Larocca; Jeffrey Schlom
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

Review 2.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

Review 3.  Poxvirus vectors as HIV/AIDS vaccines in humans.

Authors:  Carmen Elena Gómez; Beatriz Perdiguero; Juan Garcia-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

4.  Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.

Authors:  M W Carroll; W W Overwijk; R S Chamberlain; S A Rosenberg; B Moss; N P Restifo
Journal:  Vaccine       Date:  1997-03       Impact factor: 3.641

5.  Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

Authors:  K H Leong; A J Ramsay; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Authors:  Charani Ranasinghe; Fiona Eyers; John Stambas; David B Boyle; Ian A Ramshaw; Alistair J Ramsay
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

7.  Murine norovirus: propagation, quantification, and genetic manipulation.

Authors:  Seungmin Hwang; Bader Alhatlani; Armando Arias; Sarah L Caddy; Constantina Christodoulou; Juliana Bragazza Cunha; Ed Emmott; Marta Gonzalez-Hernandez; Abimbola Kolawole; Jia Lu; Christine Rippinger; Frédéric Sorgeloos; Lucy Thorne; Surender Vashist; Ian Goodfellow; Christiane E Wobus
Journal:  Curr Protoc Microbiol       Date:  2014-05-01

8.  Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression.

Authors:  G W Holzer; G Remp; G Antoine; M Pfleiderer; O M Enzersberger; W Emsenhuber; T Hämmerle; F Gruber; C Urban; F G Falkner; F Dorner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Identification and characterization of three immunodominant structural proteins of fowlpox virus.

Authors:  Denise Boulanger; Philip Green; Brenda Jones; Gwenn Henriquet; Lawrence G Hunt; Stephen M Laidlaw; Paul Monaghan; Michael A Skinner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  The genome of canarypox virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.